BioSpace News Archive

Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections

Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections.

July 13, 2022
·
2 min read
BioCapital

Advarra Launches Cloud-Based Secure Document Exchange to Accelerate Study Startup

Advarra, the market leader in regulatory review solutions, clinical research technology for sites and sponsors, and research quality and compliance consulting services, today announced the release of an end-to-end Secure Document Exchange solution within the Advarra eRegulatory Management (eReg) system.

July 13, 2022
·
4 min read
Biotech Beach

The Impact of Urinary Incontinence Related to Overactive Bladder on Long-Term Care Residents and Facilities in the U.S. Highlighted in New Survey

Urovant Sciences, a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced the peer-reviewed journal publication of the findings from a survey of Directors of Nursing (DONs) in U.S. long-term care settings.

July 13, 2022
·
8 min read
Pharm Country

miR Scientific is proud to announce the commercial availability of the miR Sentinel™ Prostate Cancer Test

miR Scientific, LLC announces the miR Sentinel™ Prostate Cancer Test is now commercially available in the United States, Puerto Rico and select international markets.

July 13, 2022
·
4 min read
Lone Star Bio

Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications

Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today that it has received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT.

July 13, 2022
·
1 min read
Lone Star Bio

QSAM Biosciences Receives Third U.S. Patent for Clinical-Stage Radiopharmaceutical Drug Candidate CycloSam®

QSAM Biosciences Inc. (OTCQB: QSAM) (the “Company”), a company developing next-generation targeted therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®).

July 13, 2022
·
4 min read
High Prevalence of Hearing Disorders among both Young and Old Populations can be Expected to Drive Audiology Devices Market Revenue Growth

The global audiology devices market size is expected to reach USD 17.43 Billion in 2030 and register a revenue CAGR of 5.3% over the forecast period, according to latest report by Reports and Data.

July 13, 2022
·
6 min read
North America Cardiac Monitoring Market is Expected to Register a Rapid Growth: High Demand for ECG, Mobile Cardiac Telemetry Devices, and Others

The global cardiac monitoring market size is expected to reach USD 32.18 Billion in 2030 and register a revenue CAGR of 3.8% over the forecast period, according to latest report by Reports and Data.

July 13, 2022
·
6 min read
Increased the Prevalence of HAIs Across the Globe is Expected to Increase Demand for Hospital Acquired Infection Treatment Market

Our market experts have determined the current financial positions of the leading industry players in the report leveraging advanced analytical tools such as Porter’s Five Forces Analysis, SWOT analysis, and investment assessment.

July 13, 2022
·
5 min read
High Incidence of Knee Problems Can Expect to Drive Asia Pacific Knee Replacement Implants Market Growth

The global knee replacement implants market size is expected to reach USD 17.45 Billion in 2030 and register a revenue CAGR of 5.3% over the forecast period, according to latest report by Reports and Data.

July 13, 2022
·
6 min read